Addressing Health Literacy With a Tailored Survivorship Care Plan

Launched by EMORY UNIVERSITY · Nov 4, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how a special care plan can help Black or African American men with prostate cancer better understand and access the care they need after treatment. The study compares two types of care plans: one that is tailored to meet the needs of patients with lower reading and writing skills and another that follows standard guidelines. The goal is to see if the tailored plan, which includes easy-to-understand information, helps patients feel more involved in their health care and improves their quality of life.

To join this study, participants need to be Black or African American men who have completed treatment for localized or oligometastatic prostate cancer within the past 1 to 4 years and are currently disease-free. They should also be able to understand English and give their consent to participate. Those with certain cognitive impairments or recurrent cancer, among other criteria, will not be eligible. If you participate, you can expect to receive personalized support and information about your health care needs, which may help you navigate life after treatment more easily.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Black and African American men who are disease-free after completing primary surgery and/or radiation treatment for localized or oligometastatic prostate cancer between 1 to 4 years prior to enrollment. (Race/ethnicity per medical records and self report)
• • Patients who are still receiving adjuvant androgen deprivation therapy following primary radiation with non-palliative intent may be included
• Exclusion Criteria:
• • Dementia or cognitive impairment per provider clinical assessment
• • Unable to give informed consent in the judgement of the patient's oncology provider
• • Recurrent prostate cancer after primary treatment
• • Less than 18 years of age at the time of informed consent
• • Diagnosis of active second malignancy requiring treatment
• • Individuals who are not able to clearly understand English since the outcome measures require understanding of English